Orchard Therapeutics plc ADR (ORTX)

전일 마감가:

$16.70

열려 있는:

$0

하루 거래량:

0

시가총액:

$380.11M

수익:

$21.84M

순이익/손실:

$-72.92M

주가수익비율:

0.00

EPS:

-6.2

순현금흐름:

$-94.41M

1주 성능:

-100.00%

1개월 성능:

-100.00%

6개월 성능:

-100.00%

1년 성능:

-100.00%

1일 변동 폭

$0.00

$0.00

52주 변동 폭

$0.00

$16.72

Orchard Therapeutics plc ADR Stock (ORTX) Company Profile

명칭

Orchard Therapeutics plc ADR

부문

Healthcare (1213)

산업

Biotechnology (696)

전화

44 20 3 808 8286

주소

108 Cannon Street, London

직원

259

트위터

@orchard_tx

다음 수익 날짜

2023-11-13

최신 SEC 제출 서류

ORTX's Discussions on Twitter

Orchard Therapeutics plc ADR Stock (ORTX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2021-12-29	재개	Cantor Fitzgerald	Overweight
2021-11-16	다운그레이드	JP Morgan	Neutral → Underweight
2021-08-18	다운그레이드	JP Morgan	Overweight → Neutral
2021-03-02	재개	JP Morgan	Overweight
2021-03-02	개시	Stifel	Buy
2021-01-07	개시	Cantor Fitzgerald	Overweight
2020-06-01	재개	Oppenheimer	Outperform
2019-09-17	개시	Guggenheim	Buy
2019-09-05	개시	Barclays	Overweight
2018-12-17	업그레이드	Goldman	Neutral → Buy
2018-11-26	개시	Goldman	Neutral
2018-11-26	개시	JP Morgan	Overweight
2018-11-26	개시	Wedbush	Outperform

모두보기

Orchard Therapeutics plc ADR 주식(ORTX)의 최신 뉴스

Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy

GlobeNewswire Inc.

Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases

GlobeNewswire Inc.

Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD

GlobeNewswire Inc.

Orchard Therapeutics Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH

GlobeNewswire Inc.

Orchard Therapeutics plc ADR (ORTX) 재무 분석

Orchard Therapeutics plc ADR (ORTX) 매출 2024

Orchard Therapeutics plc ADR (ORTX) 순이익 2024

Orchard Therapeutics plc ADR (ORTX) 현금흐름 2024

Orchard Therapeutics plc ADR (ORTX) 주당 순이익 2024